Case Name (Date)

Fust et al. v. Gilead Sciences, Inc.
23-at-1244, E.D. Cal.
(Sept. 2023)


Product/Service

Remdesivir


Allegations

Falsely marketing Remdesivir as safe and effective against COVID-19 without disclosing its limitations and adverse events, including fatalities


Status

Pending



The Latest

Filters

AARP Membership

Ad Alert

AARP Membership

The only thing more “ridiculous” than the touted benefits is the cancellation process.


Show More